Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Covid-19 in Philadelphia-negative myeloproliferative neoplasms: a GIMEMA survey on incidence, clinical management and vaccine
Leukemia ( IF 11.4 ) Pub Date : 2022-08-13 , DOI: 10.1038/s41375-022-01675-1
M Breccia ₁ , A Piciocchi ₂ , M Messina ₂ , S Soddu ₂ , V De Stefano ₃ , M Bellini ₄ , A Iurlo ₅ , B Martino ₆ , S Siragusa ₇ , F Albano ₈ , B Mora ₉ , P Fazi ₂ , M Vignetti ₂ , P Guglielmelli ₁₀ , F Palandri ₁₁

Affiliation

Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
GIMEMA Foundation, Franco Mandelli Onlus, Rome, Italy.
Section of Hematology, Department of Radiological and Hematological Sciences, Catholic University School of Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Department of Haematology, "Papa Giovanni XXIII" Hospital, Bergamo, Italy.
Foundation IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
Hematology Unit, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
Dipartimento PRO.Mi.SE, UniPA, Palermo, Italy.
Hematology and Stem Cell Transplantation Unit, Department of Emergency and Organ Transplantation (D.E.T.O.), University of Bari "Aldo Moro", Bari, Italy.
Department of Medicine and Surgery, University of Insubria, ASST Sette Laghi, Varese, Italy.
CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.